Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/mL : The “PSA negative” patients
Alison J. Birtle, Alex Freeman, John R. W. Masters, Heather A. Payne, Stephen J. Harland, Contributors to the BAUS Section of Oncology Cancer RegistryVolume:
98
Year:
2003
Language:
english
Pages:
6
DOI:
10.1002/cncr.11821
File:
PDF, 108 KB
english, 2003